Cysteamine hydrochloride
盐酸硫乙胺
Report date: 2024/03/28 11:37:30
NME
Base Information
Drug NameCysteamine hydrochloride
Drug Alias Name +[10]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in ChinaN/A
Original Approved Country/Territory
Original Approved Date2012/10/02
Country/Territory +[9]
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A
Develop Information
Active CompaniesRecordati Rare Diseases IncLeadiant Biosciences IncViatris Inc
Inactive CompaniesLucane PharmaNational Eye Institute (Nei)
Active Indications
Inactive Indications